Pharmacognosy Research logo
Submit
Pharmacognosy ResearchACADEMIC PUBLISHING
Article

Amentoflavone, New Hope against SARS-CoV-2: An Outlook through its Scientific Records and an in silico Study

1, 1, 2, 3, 4, 5, 6, 7, 8, 9, 9, 9, 9, 9, 9, 9

  1. 1Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Dhaka, BANGLADESH.
  2. 2Department of Biomedical Engineering, Huazhong University of Science and Technology, Wuhan, CHINA.
  3. 3Department of Bioscience and Biotechnology, Banasthali Vidyapith, Rajasthan, INDIA.
  4. 4Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, BANGLADESH.
  5. 5Faculty of Science, Liverpool John Moores University, Liverpool L33AF, England, UK.
  6. 6Ethnobotany and Natural product Research Laboratory, Department of Life Science and Bioinformatics, Assam University, Silchar-11, Assam, INDIA.
  7. 7School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, England, UK.
  8. 8Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran,, IRAN., 9Department of Pharmacognosy and Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IRAN.
  9. 9Department of Nutrition and Dietetics, Faculty of Pharmacy, and Centre for Healthy Living, University of Concepción, Concepción, CHILE.

CORRESPONDENCE

Javad Sharifi-Rad, CHILE.

Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran,, IRAN.

javad.sharifirad@gmail.com

Received: 30-03-2021; Accepted: 25-05-2021.

Volume 13, Issue 3 · pp. 149-157 · 2021 · DOI: 10.5530/pres.13.3.7

ABSTRACT

Background: The plant-derived bioflavonoid amentoflavone has many important biological activities, among them remarkable antiviral effects, even against severe acute respiratory syndrome Coronavirus (SARS-CoV). It inhibits severe acute respiratory syndrome coronavirus (SARS-CoV) with an IC50 value of 8.3 μM. TMPRSS-2 activity is now thought to be the only factor necessary for cell entry and viral pathogenesis). In comparison, 3CLPRO is needed for COVID-19 replication and maturation during its life cycle.Aim: This study aims to perform an in silico study on amentoflavone activity against structural and non-structural severe acute respiratory syndrome coronavirus (SARS-CoV)-2 3-chymotrypsin-like protease (3CLPRO) and human transmembrane protease serine 2 (TMPRSS-2) proteins.Materials and Methods: Molecular docking studies were carried out using compounds against 3CLPRO and TMPRSS-2 proteins through the Swiss model, Uniport, PROCHECK, Swiss PDB viewer, PyMol, PyRx, and Desmond (Schrödinger package) computerized software.Results: Amentoflavone showed strong interactions -9.5 and -7.4 kcal/mol with 3CLPRO and TMPRSS2 proteins, respectively. In any case, it had higher binding affinities than currently approved antiviral drugs, which are underutilized in coronavirus disease (COVID-19).Conclusion: Amentoflavone may be one of the potential leads (drug candidate) to fight human coronavirus, including SARS-CoV-2. Further in vivo studies are needed to support the findings of this study.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Hossain, R., Islam, M. T., Ray, P., Jain, D., Saikat, A. S. M., Nahar, L., Talukdar, A. D., Sarker, S., Ayatollahi, S. A., Martorell, M., Kobarfard, F., Martins, N. C., Al-Khafaji, K., Docea, A. O., Calina, D., & Sharifi-Rad, J. (2021). Amentoflavone, New Hope against SARS-CoV-2: An Outlook through its Scientific Records and an in silico Study. Pharmacognosy Research, 13(3), 149-157. https://doi.org/10.5530/pres.13.3.7

    Copyright and licence

    © 2021 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0